Ophthalmic Dosage Forms

Ophthalmic Product Failures Like Irritation? Sterility and Quality Fixes

Identifying the right symptoms is critical in mitigating quality failures associated with ophthalmic dosage forms. Signs of product failure typically emerge during both manufacturing processes and post-market surveillance. Common symptoms…

Sterility Test Failure in eye drop manufacturing: risk assessment for sterility assurance

Recognizing early symptoms of a sterility test failure is crucial for effective risk management. Common indicators include:Click to read the full article.

E&L Failure at stability pull: packaging integrity and CCIT justification

The investigation begins by identifying the symptoms observed during the stability testing pull. These signals can be both qualitative and quantitative. Symptoms of E&L failure might manifest as follows:Click to…

Ccit Failure in eye drop manufacturing: packaging integrity and CCIT justification

Recognizing early signals of CCIT failure is crucial. Symptoms may arise during testing processes, product inspections, or even from customer complaints. Common observations include:Click to read the full article.

Pet Failure for multi-dose products: how to avoid repeat 483 observations

Identifying symptoms of pet failures is the first step in a robust investigation. Common signals may include:Click to read the full article.

Pet Failure for multi-dose products: FDA-ready investigation report and batch disposition

The first step in addressing pet failure is recognizing the symptoms or signals that indicate a potential issue. Symptoms may emerge during routine QC testing, process monitoring, or following reports…

Ph Drift after packaging change: FDA-ready investigation report and batch disposition

The initial step in addressing pH drift involves recognizing symptoms or signals that indicate a potential issue:Click to read the full article.

Ccit Failure at stability pull: risk assessment for sterility assurance

Recognizing the early signs of a Ccit failure during stability testing is crucial for rapid response. Below are common symptoms that may indicate an issue:Click to read the full article.

Fill Volume Variability at stability pull: risk assessment for sterility assurance

Identifying symptoms of fill volume variability begins on the production floor or within the laboratory environment. Observational signals may include the following:Click to read the full article.

Media Fill Failure during method transfer: packaging integrity and CCIT justification

Detecting early signals of media fill failure is crucial in the prevention of non-sterile production batches. Common symptoms may include:Click to read the full article.

Osmolality Oos during sterile filtration: packaging integrity and CCIT justification

Identifying signals that indicate potential OOS results is critical. Symptoms can manifest in the laboratory through various means:Click to read the full article.

Media Fill Failure after packaging change: FDA-ready investigation report and batch disposition

Media fill tests are a critical component of validating aseptic processing in pharmaceutical manufacturing. A failure in this area could manifest various symptoms, leading to operational and regulatory consequences. Some…